4/17
08:02 pm
alxo
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules [Yahoo! Finance]
Neutral
Report
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules [Yahoo! Finance]
4/17
04:05 pm
alxo
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
Low
Report
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
4/13
08:30 am
alxo
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
Medium
Report
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
3/19
09:00 am
alxo
ALX Oncology (ALXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $5.00 price target on the stock.
Low
Report
ALX Oncology (ALXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $5.00 price target on the stock.
3/10
08:03 am
alxo
ALX Oncology (ALXO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $4.00 price target on the stock.
Medium
Report
ALX Oncology (ALXO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $4.00 price target on the stock.
3/8
06:42 am
alxo
ALX Oncology initiated with a Buy at UBS [Yahoo! Finance]
Low
Report
ALX Oncology initiated with a Buy at UBS [Yahoo! Finance]
3/6
10:58 am
alxo
ALX Oncology (ALXO) is now covered by UBS Group AG. They set a "buy" rating and a $6.00 price target on the stock.
Low
Report
ALX Oncology (ALXO) is now covered by UBS Group AG. They set a "buy" rating and a $6.00 price target on the stock.
3/3
11:42 pm
alxo
ALX Oncology Highlights $150M Raise, Evorpacept Breast Cancer Push and EGFR ADC ALX2004 Update [Yahoo! Finance]
Medium
Report
ALX Oncology Highlights $150M Raise, Evorpacept Breast Cancer Push and EGFR ADC ALX2004 Update [Yahoo! Finance]
3/1
09:26 am
alxo
ALX Oncology: Evorpacept For ASPEN-09 Presses On With 2 Key Milestones [Seeking Alpha]
Medium
Report
ALX Oncology: Evorpacept For ASPEN-09 Presses On With 2 Key Milestones [Seeking Alpha]
2/28
09:03 am
alxo
ALX Oncology Holdings Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
ALX Oncology Holdings Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/27
06:12 pm
alxo
ALX Oncology outlines pivotal trial readiness by end of 2026 with expanded ASPEN-09 study and $150M financing [Seeking Alpha]
Low
Report
ALX Oncology outlines pivotal trial readiness by end of 2026 with expanded ASPEN-09 study and $150M financing [Seeking Alpha]
2/27
04:34 pm
alxo
ALX Oncology Holdings Inc (ALXO) Q4 2025 Earnings Call Highlights: Strong Clinical Progress and ... [Yahoo! Finance]
Low
Report
ALX Oncology Holdings Inc (ALXO) Q4 2025 Earnings Call Highlights: Strong Clinical Progress and ... [Yahoo! Finance]
2/27
08:28 am
alxo
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
2/27
08:00 am
alxo
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Medium
Report
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
2/19
08:53 am
alxo
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 [Yahoo! Finance]
High
Report
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026 [Yahoo! Finance]
2/19
08:53 am
alxo
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 [Yahoo! Finance]
High
Report
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 [Yahoo! Finance]
2/19
08:33 am
alxo
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
High
Report
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
2/19
08:30 am
alxo
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
High
Report
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
2/9
11:32 am
alxo
Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Medium
Report
Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
2/5
07:18 am
alxo
ALX Oncology (NASDAQ:ALXO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Medium
Report
ALX Oncology (NASDAQ:ALXO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
1/31
03:52 pm
alxo
ALX Oncology Announces Pricing of Underwritten Offering [Yahoo! Finance]
Low
Report
ALX Oncology Announces Pricing of Underwritten Offering [Yahoo! Finance]
1/30
08:32 am
alxo
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology's Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer [Yahoo! Finance]
Medium
Report
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology's Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer [Yahoo! Finance]
1/30
08:30 am
alxo
ALX Oncology Announces Pricing of Underwritten Offering
High
Report
ALX Oncology Announces Pricing of Underwritten Offering
1/30
08:15 am
alxo
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer
High
Report
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer